Skip to main content

Landos Biopharma, Inc.

LABPDelisted May 23, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001785345

Landos Biopharma, Inc. was delisted on May 23, 2024; its insiders filed their last Form 4 on May 23, 2024; 16 institutions reported holding it in 13F filings for Q1 2024, worth $34.9M in total; no superinvestor held it.

13F holders, Q1 2022

Institutional positions in Landos Biopharma, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
45
+6 vs. Q4 2021
Shares held
23.9M
−1.04M (−4.2%) vs. Q4 2021
Total value
$35.3M
−$84.5M (−70.6%) vs. Q4 2021
New holders
9
12 more added
Sold out
3
13 more reduced

1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting LABP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 45 institutions
Q1 2021: 47 institutionsQ2 2021: 33 institutionsQ3 2021: 35 institutionsQ4 2021: 40 institutionsQ1 2022: 45 institutionsQ2 2022: 35 institutionsQ3 2022: 31 institutionsQ4 2022: 23 institutionsQ1 2023: 20 institutionsQ2 2023: 8 institutionsQ3 2023: 11 institutionsQ4 2023: 10 institutionsQ1 2024: 16 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2022: $35.3M
Q1 2021: $218.9MQ2 2021: $261.4MQ3 2021: $331.1MQ4 2021: $119.8MQ1 2022: $35.3MQ2 2022: $16.4MQ3 2022: $14.0MQ4 2022: $7.87MQ1 2023: $4.63MQ2 2023: $6.27MQ3 2023: $5.93MQ4 2023: $5.58MQ1 2024: $34.9MQ2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding LABP and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 202416$34.9M
Q4 202310$5.58M
Q3 202311$5.93M
Q2 20238$6.27M
Q1 202320$4.63M
Q4 202223$7.87M
Q3 202231$14.0M
Q2 202235$16.4M
Q1 202245$35.3M
Q4 202140$119.8M
Q3 202135$331.1M
Q2 202133$261.4M
Q1 202147$218.9M

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Landos Biopharma, Inc.; share changes are against Q4 2021.

Institutions holding LABP in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Perceptive Advisors LLC14,869,915$21.9M0.46%00.0%Unchanged
RTW Investments, LP4,275,722$6.31M0.13%00.0%Unchanged
OUP Management Co., LLC1,827,478$2.70M2.05%00.0%Unchanged
BlackRock Inc.520,308$767.0K0.00%+49,880+10.6%Added
Renaissance Technologies LLC340,500$502.0K0.00%+169,400+99.0%Added
JPMorgan Chase & Co292,377$432.0K0.00%−7,239−2.4%Reduced
OrbiMed Advisors LLC283,217$418.0K0.01%00.0%Unchanged
Bridgeway Capital Management, LLC159,000$235.0K0.00%+159,000New
Vanguard Group Inc159,001$234.0K0.00%−145,797−47.8%Reduced
Jacobs Levy Equity Management, Inc158,875$234.0K0.00%+158,875New
Macquarie Group Ltd147,182$217.0K0.00%00.0%Unchanged
Botty Investors LLC128,750$190.0K0.07%00.0%Unchanged
Geode Capital Management, LLC113,455$167.0K0.00%−469−0.4%Reduced
State Street Corp110,196$163.0K0.00%+2,600+2.4%Added
Walleye Capital LLC93,533$138.0K0.00%−11,675−11.1%Reduced
Two Sigma Investments, LP73,651$109.0K0.00%+18,873+34.5%Added
Millennium Management LLC60,968$90.0K0.00%+60,968New
Bank of America Corp56,321$83.0K0.00%+25,096+80.4%Added
Northern Trust Corp45,696$67.0K0.00%−311−0.7%Reduced
Two Sigma Advisers, LP42,300$62.0K0.00%+16,600+64.6%Added
Walleye Trading LLC33,132$49.0K0.00%−10,147−23.4%Reduced
Goldman Sachs Group Inc19,537$29.0K0.00%+1,969+11.2%Added
Bank of New York Mellon Corp16,982$25.0K0.00%+4,003+30.8%Added
D. E. Shaw & Co., Inc.16,988$25.0K0.00%+16,988New
Charles Schwab Investment Management Inc10,349$16.0K0.00%−3,611−25.9%Reduced
STRS Ohio11,400$16.0K0.00%00.0%Unchanged
Morgan Stanley7,260$11.0K0.00%−146,516−95.3%Reduced
Tower Research Capital LLC (TRC)5,974$9.00K0.00%+2,002+50.4%Added
Allworth Financial LP5,286$8.00K0.00%00.0%Unchanged
Deutsche Bank AG2,543$4.00K0.00%−300−10.6%Reduced
New York State Common Retirement Fund2,700$4.00K0.00%−41−1.5%Reduced
Citigroup Inc2,806$4.00K0.00%+358+14.6%Added
American International Group, Inc.2,324$3.00K0.00%−163−6.6%Reduced
California State Teachers Retirement System1,959$3.00K0.00%+393+25.1%Added
FMR LLC1,383$2.00K0.00%+1,383New
Acadian Asset Management LLC1,344$1.00K0.00%−6,930−83.8%Reduced
Legal & General Group Plc408$1.00K0.00%00.0%Unchanged
Ameritas Investment Partners, Inc.515$1.00K0.00%00.0%Unchanged
Manchester Capital Management LLC406$1.00K0.00%00.0%Unchanged
Barclays PLC761$1.00K0.00%+761New
Amalgamated Bank802$1.00K0.00%+802New
Advisor Group Holdings, Inc.418$1.00K0.00%+418New
Amalgamated Financial Corp.802$1.00K0.00%+802New
Royal Bank of Canada488$00.00%−7,663−94.0%Reduced
Wells Fargo & Company200$00.00%+186+1,328.6%Added
Logos Global Management LP0$00.00%−1,375,000−100.0%Sold out
Jump Financial, LLC0$00.00%−15,200−100.0%Sold out
UBS Group AG0$00.00%−3,805−100.0%Sold out
Carroll Financial Associates, Inc.––––Not filed